Biogen Spinraza Treatment Delays Show COVID-19 Is Already Impacting Hospital Treatments

Biogen confirmed that some patients treated with Spinraza are temporarily having their dosing postponed as hospital systems brace for COVID-19, potentially a broader issue for the industry. 

LED Display - Airport flight status board (Photo + 3D Rendering)
Some treatments of Spinraza are being delayed • Source: Shutterstock

More from COVID-19

More from Scrip